ADO 3.67% 2.1¢ anteotech ltd

vitamin d - diasorin, page-4

  1. 1,507 Posts.
    Great work Greg.

    I'm not so sure about this though:
    You can clearly see that their Vitamin D test has a 55% market share. And they are looking at Euro10-20m per year for this test alone.
    Looking at the presentation, I interpret it as saying the company expects an additional 10-20m in revenue between now and 2015. On the second page of your last link you can see Diasorin expects an increase from 40m - 60m tests / annum by 2015.

    Now, I don't know the cost of each test, but if you add up the number of tests (w/w market size * Diasorin market share) it totals 344.5m tests. The company provides guidance of sales of EUR450, which is EUR1.3 / test.

    If we use 1EUR / Vit D test, then the increase of 40m tests to 60m tests would be the upper end of the EUR20m / annum stated.

    I therefore conclude that Diasorin currently has a EUR40m market and is aiming to have a EUR60m market by 2015.

    I welcome alternative interpretations...
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
-0.001(3.67%)
Mkt cap ! $52.28M
Open High Low Value Volume
2.2¢ 2.3¢ 2.1¢ $7.812K 349.8K

Buyers (Bids)

No. Vol. Price($)
7 828094 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 1102151 4
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.